In Finjan, Inc. v. Blue Coat Systems, Inc., the United States Court of Appeals for the Federal Circuit recently affirmed-in-part, reversed-in-part, and remanded the case to the district court. Notably, however, the Federal Circuit found no error in the district court's subject matter eligibility determination, meaning the claims of Finjan's '844 patent were patent eligible under 35 U.S.C. 101. Perhaps more remarkable, the claims of the '844 patent relate to virus-screening and were determined to be not abstract. Still more remarkable, the author of this Federal Circuit decision was Judge Dyk, who is not know as a zealous advocate for software patent eligibility.
The post Federal Circuit says Finjan virus-screening method not abstract, is patent eligible appeared first on IPWatchdog.com | Patents & Patent Law.